The endothelin-parathyroid hormone-related protein vasoactive peptide system in human endometrium: Modulation by transforming growth factor-β

Human Reproduction

Volumn 11, Issue SUPPL. 2, 1996, Pages 62-82

  Casey, M Linette ^a,b   MacDonald, Paul C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Endothelin 1; Enkephalinase; Parathyroid hormone related protein; Progestin; Transforming growth factor

Indexed keywords

ENDOTHELIN 1; GESTAGEN; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE AGENT;

ARTERY BLOOD FLOW; CONFERENCE PAPER; ENDOMETRIUM; ENZYME ACTIVITY; HUMAN; NONHUMAN; PROTEIN EXPRESSION; STROMA CELL; UTERINE ARTERY; UTERUS BLEEDING;

EID: 0030317404     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/11.suppl_2.62     Document Type: Article

References (114)

1. Abbas, S.K., Pickard, D.W., Rodda, C.P. et al. (1989) Stimulation of ovine placental calcium transport by purified natural and recombinant parathyroid hormone-related protein (PTH-rP) preparations. J. Exp. Physiol., 74, 549-552.
2. Abel, M.H. (1985) Prostanoids and menstruation. In Baird, D.T. and Michie, E.A. (eds), Mechanisms of Menstrual Bleeding. Raven Press, New York, NY, USA, pp. 139-156.
3. Altman, D.J., Schneider, S.L., Thompson, D.A. et al. (1990) A transforming growth factor-β2 (TGF-β2)-like immunosuppressive factor in amniotic fluid and localization of TGF-β2 mRNA in the pregnant uterus. J. Exp. Med., 172, 1391-1401.
4. Anzai, Y., Gong, Y., Holinka, C.F. et al. (1992) Effects of transforming growth factors and regulation of their mRNA levels in two endometrial adenocarcinoma cell lines. J. Steroid Biochem., 42, 449-455.
5. Arici, A., MacDonald, P.C. and Casey, M.L. (1996) Modulation of tranforming growth factor-β expression in human endometrial stromal cells. Biol. Reprod., 54, 463-469.
6. Arrick, B.A., Korc, M. and Derynck, R. (1990) Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol. Cancer Res., 50, 299-303.
7. Borson, D.B. and Gruenert, D.C. (1991) Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am. J. Physiol., 260, L83-L89.
8. Cameron, I.T., Davenport, A.P., van Papendorp, C. et al. (1992) Endothelin-like immuno-reactivity in human endometrium. J. Reprod. Fertil., 95, 623-628.
9. Casey, M.L. and MacDonald, P.C. (1990) Biomolecular mechanisms in human parturition: activation of uterine decidua. In d'Arcangues, C., Fraser, I.S., Newton, J.R. and Odlind, V. (eds), Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, MA, USA, pp. 305-323.
10. Casey, M.L. and MacDonald, P.C. (1993a) Modulation of endometrial blood flow: regulation of endothelin-1 biosynthesis and degradation in human endometrium. In Alexander, N.J. and d'Arcangue, C. (eds). Steroid Hormones and Uterine Bleeding. AAAS Press, Washington, DC, USA, pp. 209-224.
11. Casey, M.L. and MacDonald, P.C. (1993b) Transforming growth factor-β (TGF-β) acts as a gene-specific antiprogestin. Proc. Soc. Gynecol. Invest., 40, 69 (Abstr).
12. Casey, M.L. and MacDonald, P.C. (1994) Transforming growth factor-β1 (TGF-β1) as an antiprogestin: regulation of enkephalinase gene expression. Proc. Soc. Gynecol. Invest., 41, 149 (Abstr.).
13. Casey, M.L. and MacDonald, P.C. (1996) Transforming growth factor-β inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells. J. Clin. Endocrinol. Metab., 81, in press.
14. +-dependent 15-hydroxy-prostaglatidin dehydrogenase activity in human endometrium. Prostaglandins, 19, 115-122.
15. Casey, M.L., Gal, D., Korte, K. et al. (1985) Metabolism of arachidonic acid by human endometrial glands and stromal cells maintained in monolayer culture. In Baird, D.T. (ed.), Mechanism of Menstrual Bleeding. Serono Symposia Series, Academic Press, London, UK, pp. 107-127.
16. Casey, M.L., Smith, J.W., Nagai, K. et al. (1991) Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium. J. Biol. Chem., 266, 23041-23047.
17. Casey, M.L., Mibe, M., Erk, A. and MacDonald, P.C. (1992) Transforming growth factor-β1 stimulation of parathyroid hormone-related protein expression in human uterine cells in culture: mRNA levels and protein secretion. J. Clin. Endocrinol. Metab., 74, 950-952.
18. Casey, M.L., Mibe, M. and MacDonald, P.C. (1993a) Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J. Clin. Endocrinol. Metab., 77, 188-194.
19. Casey, M.L., Smith, J.W., Nagai, K. and MacDonald, P.C. (1993b) Transforming growth factor-β1 inhibits enkephalinase (EC 3.4.24.11) gene expression in human endometrial stromal cells and sex skin fibroblasts in culture. J. Clin. Endocrinol. Metab., 77, 144-150.
20. Casey, M.L., Erk, A. and MacDonald, P.C. (1994) Parathyroid hormone and parathyroid hormone-related protein stimulate adenylate cyclase in human endometrial stromal cells. Ann. N.Y. Acad. Sci., 734, 365-371.
21. Clark, D.A., Falbo, M., Rowley, R.B. et al. (1988) Active suppression of host vs graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-β. J. Immunol., 141, 3833-3840.
22. Clark, D.A., Flanders, K.C., Banwatt, D. et al. (1990) Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor β-2. J. Immunol., 144, 3008-3014.
23. Colletta, A.A., Howell, F.V. and Baum, M. (1989) A novel binding site for a synthetic progestagen in human breast cancer cells. J. Steroid Biochem., 33, 1055-1061.
24. Colletta, A.A., Wakefield, L.M., Howell, F.V. et al. (1990) Antiestrogens induce the secretion of active transforming growth factor β from human fetal fibroblasts. Br. J. Cancer, 62, 405-409.
25. Colletta, A.A., Wakefield, L.M., Howell, F.V. et al. (1991) The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor β. J. Clin. Invest., 87, 277-283.
26. Cunningham, F.G., MacDonald, P.C., Gant, N.F. et al. (1993) Williams Obstetrics. Appleton and Lange, Norwalk, CT, USA.
27. Daifotis, A.G., Weir, E.C., Dreyer, B.E. and Broadus, A.E. (1992) Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus. J. Biol. Chem., 267, 23455-23458.
28. Das, S.K., Flanders, K.C., Andrews, G.K. and Dey, S.K. (1992) Expression of transforming growth factor-β isoforms (β 2 and β 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology, 130, 3459-3466.
29. Davenport, A.P., Cameron, I.T., Smith, S.K. and Brown, M.J. (1991) Binding sites for iodinated endothelin-1, endothelin-2, and endothelin-3 demonstrated on human uterine glandular epithelial cells by quantitative high-resolution autoradiography. J. Endocrinol., 129, 149-154.
30. deNucci, G., Thomas, R., D'Orleans-Juste, P. et al. (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA, 85, 9797-9800.
31. Dungy, L.J., Siddiqi, T.A. and Khan, S. (1991) Transforming growth factor-β1 expression during placental development. Am. J. Obstet. Gynecol., 165, 853-857.
32. Economos, K., MacDonald, P.C. and Casey, M.L. (1992) Endothelin-1 gene expression and protein biosynthesis in human endometrium: potential modulator of endometrial blood flow. J. Clin. Endocrinol. Metab., 74, 14-19.
33. Edwards, D.R., Murphy, G., Reynold, J.J. et al. (1987) Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J., 6, 1899-1904.
34. Emoto, N. and Yanagisawa, M. (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem., 270, 15262-15268.
35. Falanga, V., Qian, S.W., Danielpour, D. et al. (1991) Hypoxia upregulates the synthesis of TGF-β1 by human dermal fibroblasts. J. Invest. Dermatol., 97, 634-637.
36. Ferguson, J.E., II, Gorman, J.V., Bruns, D.E. et al. (1992) Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. Proc. Natl. Acad. Sci. USA, 89, 8384-8388.
37. Flaumenhaft, R., Abe, M., Sato, Y. et al. (1993) Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J. Cell Biol., 120, 995-1002.
38. Gal, D., Casey, M.L., Johnston, J.M. and MacDonald, P.C. (1982) Mesenchyme-epithelial interactions in human endometrium: prostaglandin synthesis in separated cell types. J. Clin. Invest., 70, 798-805.
39. Germain, A., Attaroglu, H., MacDonald, P.C. and Casey, M.L. (1992) Parathyroid hormone-related protein mRNA in avascular human amnion. J. Clin. Endocrinol. Metab., 75, 1173-1175.
40. Glick, A.B., Flanders, K.C., Danielpour, D. et al. (1989) Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul., 1, 87-97.
41. Gold, L.I., Saxena, B., Mittal, K.R. et al. (1994) Increased expression of transforming growth factor-β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res., 54, 2347-2358.
42. Gong, Y., Anzai, Y., Murphy, L.C. et al. (1991) TGF-β gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Cancer Res., 51, 5476-5481.
43. Graham, C.H. and Lala, P.K. (1991) Mechanism of control of trophoblast invasion in situ. J. Cell. Physiol., 148, 228-234.
44. Graham, C.H., Lysiak, J.J., McCrae, K.R. and Lala, P.K. (1992) Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol. Reprod., 46, 561-572.
45. Gutmann, J.N., Burtis, W.J., Dreyer, B.E. et al. (1993) Human granulosa-luteal cells secrete parathyroid hormone-related protein in vivo and in vitro. J. Clin. Endocrinol. Metab., 76, 1314-1318.
46. Hamilton, J.A., Wojta, J., Gallichio, M. et al. (1993) Contrasting effects of transforming growth factor-β and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J. Immunol., 151, 5154-5161.
47. Hashiguchi, K., Takagi, K., Nakabayashi, M. et al. (1991) Relationship between fetal hypoxia and endothelin-1 in fetal circulation. J. Cardiovasc. Pharmacol., 17, S509-S510.
48. Head, J.R., MacDonald, P.C. and Casey, M.L. (1993) Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycle. J. Clin. Endocrinol. Metab., 76, 769-776.
49. Hellman, P., Ridefelt, P., Juhlin, C. et al. (1992) Parathyroid-like regulation of parathyroid-hormone-related protein release and cytoplasmic calcium in cytotrophoblast cells of human placenta. Arch. Biochem. Biophys., 293, 174-180.
50. Iqbal, M.J. and Colletta, A.A. (1987) Characterisation of gestodene binding to the estrogen receptor in human malignant breast. Anticancer Res., 7, 45-48.
51. Iqbal, M.J. and Valyani, S.H. (1988) Evidence for a novel binding site for the synthetic progestogen. gestodene on oestrogen receptor in human malignant tissue. Anticancer Res., 8, 351-354.
52. Jeng, M.H. and Jordon, V.C. (1991) Growth stimulation and differential regulation of transforming growth factor-β1 (TGF-β1), TGF-β2, and TGF-β3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Mol. Endocrinol., 5, 1120-1128.
53. Kauma, S., Matt, D., Strom, S. et al. (1990) Interleukin-1β, human leukocyte antigen HLA-DRα, and transforming growth factor-β expression in endometrium, placenta, and placental membranes. Am. J. Obstet. Gynecol., 163, 1430-1437.
54. Kerr, L.D., Miller, D.B. and Matrisian, L.M. (1990) TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell, 61, 267-278.
55. Kim, S.J., Angel, P., Lafyatis, R. et al. (1990) Autoinduction of transforming growth factor-β1 is mediated by the AP-1 complex. Mol. Cell. Biol., 10, 1492-1497.
56. Knabbe, C., Lippman, M.E., Wakefield, L.M. et al. (1987) Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417-428.
57. Komm, B.S., Terpening, C.M., Benz, D.J. et al. (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science, 241, 81-84.
58. Korte, K., MacDonald, P.C., Johnston, J.M. et al. (1983) Metabolism of arachidonic acid and prostanoids in human endometrial stromal cells in monolayer culture. Biochim. Biophys. Acta, 752, 423-433.
59. Kourembanas, S. (1992) Hypoxic responses of the neonatal endothelium. Semin. Perinatol., 16, 140-146.
60. Kourembanas, S., Hannan, R.L. and Faller, D.V. (1990) Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J. Clin. Invest., 86, 670-674.
61. Kourembanas, S., Marsden, P.A., McQuillan, L.P. and Faller, D.V. (1991) Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest., 88, 1054-1057.
62. Kubota, T., Taguchi, M., Kamada, S. et al. (1995) Endothelin synthesis and receptors in human endometrium throughout the normal menstrual cycle. Hum. Reprod., 10, 2204-2208.
63. Kyprianou, N., English, H.F., Davidson, N.B. and Isaacs, J.T. (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166.
64. Landren, B.M., Lundstrom, V., Eneroth, P. and Johannisson, E. (1985) The effect of a prostaglandin synthetase inhibitor on the hormonal profile of the endometrium in women. Am. J. Obstet. Gynecol., 151, 361-368.
65. Le, S.Q., Casey, M.L. and MacDonald, P.C. (1994) Regulation of urokinase plasminogen activator receptor expression in human endometrial stromal cells. J. Soc. Gynecol. Invest., 2, 362 (Abstr.).
66. Lea, R.G., Flanders, K.C., Harley, C.B. et al. (1992) Release of a transforming growth factor (TGF)-β2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGF-β2. J. Immunol., 148, 778-787.
67. Letarte, M., Vera, S., Tran, R. et al. (1988) Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med., 168, 1247-1253.
68. Lockwood, C.J., Nemerson, Y., Guller, S. et al. (1993) Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J. Clin. Endocrinol. Metab., 76, 231-236.
69. López-Farré, A., Gómez-Garre, D., Bernabeu, F. and López-Novoa, J. (1991) A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J. Physiol., 444, 513-522.
70. Lorkowski, G., Zijderhand-Bleekemolen, J.E., Erdös, E.G. et al. (1987) Neutral endopeptidase-24.11 (enkephalinase). Biosynthesis and localization in human fibroblasts. Biochem. J., 248, 345-350.
71. Machida, C.M., Muldoon, L.L., Rodland, K.D. and Magun, B.E. (1988) Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor-β. Mol. Cell. Biol., 8, 2479-2483.
72. Makarainen, L. and Ylikorkala, O. (1992) Menstrual blood loss in dysmenorrhea: effects of proquazone and indomethacin. Br. J. Obstet. Gynaecol., 90, 570-572.
73. Manova, K., Paynton, B.V. and Bachvarova, R.F. (1992) Expression of activins and TGF-β1 and -β2 RNAs in early postimplantation mouse embryos and uterine decidua. Mech. Ageing Dev., 36, 141-152.
74. Marbaix, E., Donnex, J., Courtoy, P.J. and Eeckhout, Y. (1992) Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. USA, 89, 11789-11793.
75. Markee, J.E. (1940) Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib. Embryol., 28, 219-308.
76. Marsh, M.M., Butt, A.R., Riley, S.C. et al. (1995) Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant). Hum. Reprod., 10, 2584-2589.
77. Marshburn, P.B., Arici, A.M. and Casey, M.L. (1994) Expression of transforming growth factor-β (TGF-β1) mRNA and the modulation of DNA synthesis by TGF-β1 in human endometrial cells. Am. J. Obstet. Gynecol., 170, 1152-1158.
78. Martin, T.J., Allan, E.H., Caple, I.W. et al. (1989) Parathyroid hormone-related protein. Rec. Prog. Horm. Res., 45, 467-502.
79. Matrisian, L.M., Ganser, G.L., Kerr, L.D. et al. (1992) Negative regulation of gene expression by TGF-β. Mol. Reprod. Dev., 32, 111-120.
80. Matsumura, Y., Ikegawa, R., Tsukahara, Y. et al. (1990) Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett., 272, 166-170.
81. Melampy, R.M., Anderson, L.L. and Kragt, C.L. (1964) Uterus and life span of rat corpora lutea. Endocrinology, 74, 501-504.
82. Miyazono, K., Ichijo, H. and Heldin, C.H. (1993) Transforming growth factor-β: latent forms, binding proteins, and receptors. Growth Factors, 8, 11-22.
83. Mok, L.L., Nickols, G.A., Thompson, J.C. and Cooper, C.W. (1989) Parathyroid hormone as a smooth muscle relaxant. Endocr. Rev., 10, 420-436.
84. Murphy, L.C. and Dotzlaw, H. (1989) Regulation of transforming growth factor α and transforming growth factor β messenger ribonucleic acid abundance in T-47D, human breast cancer cells. Mol. Endocrinol., 3, 611-617.
85. Murphy, L.J., Gong, Y. and Murphy, L.C. (1992) Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. J. Steroid Biochem., 41, 3-8.
86. Opgenorth, T.J., Wu-Wong, J.R. and Shiosaki, K. (1992) Endothelin-converting enzymes. FASEB J., 6, 2653-2659.
87. B receptor subtype across the menstrual cycle. J. Clin. Endocrinol. Metab., 75, 1545-1549.
88. Pohl, U. and Busse, R. (1989) Differential vascular sensitivity to luminally and adventitially applied endothelin-1. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), 5188-5190.
89. Pollow, K., Juchem, M., Grill, H.J. et al. (1990) Lack of binding of gestodene to estrogen receptor in human breast cancer tissue. Eur. J. Cancer, 26, 608-610.
90. Ranganathan, G., Blatti, S.P., Subramaniam, M. et al. (1991) Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type-β1. J. Biol. Chem., 266, 496-501.
91. Rodda, C.P., Kubota, M., Heath, J.A. et al. (1988) Evidence for a novel parathyroid hormone-related protein in fetal parathyroid glands and sheep placenta: comparisons with a similar protein implicated in human hypercalcemia of malignancy. J. Endocrinol., 117, 261-271.
92. Salamonsen, L.A., Butt, A.R., Macpherson, A.M. et al. (1992) Immunolocalization of the vasoconstrictor endothelin in human endometrium during the menstrual cycle and in umbilical cord at birth. Am. J. Obstet. Gynecol., 167, 163-167.
93. Schatz, F. and Lockwood, C.J. (1993) Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab., 77, 621-625.
94. Selick, C.E., Horowitz, G.M., Gratch, M. et al. (1994) Immunohistochemical localization of transforming growth factor-β in human implantation sites. J. Clin. Endocrinol. Metab., 78, 592-596.
95. Shigeno, T., Mima, T., Takakura, K. et al. (1989) Endothelin-1 acts in cerebral arteries from the adventitial but not from the luminal side. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), 5174-5176.
96. Sokolovsky, M., Galron, L., Kloog, Y. et al. (1990) Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. USA, 87, 4702-4706.
97. Sporn, M.B. and Roberts, A.B. (1989) Transforming growth factor-β: multiple actions and potential clinical applications. J. Am. Med. Assoc., 262, 938-941.
98. Strahle, U., Boshart, M., Klock, G. et al. (1989) Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature, 339, 629-632.
99. Tamada, H., McMaster, M.T., Flanders, K.C. et al. (1990) Cell type-specific expression of transforming growth factor-β1 in the mouse uterus during the periimplantation period. Mol. Endocrinol., 4, 965-972.
100. Thiede, M.A. and Rodan, G.A. (1988) Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science, 242, 278-280.
101. Thiede, M.A., Daifotis, A.G., Weir, B.C. et al. (1990) Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium. Proc. Natl. Acad. Sci. USA, 87, 6969-6973.
102. Thiede, M.A., Harm, S.C., Hasson, D.M. and Gardner, R.M. (1991a) In vivo regulation of PTH-rP messenger ribonucleic acid in the rat uterus by 17β-estradiol. Endocrinology, 128, 2317-2323.
103. Thiede, M.A., Harm, S.C., McKee, R.L. et al. (1991b) Expression of the parathyroid hormone-related gene in the avian oviduct: potential role as a local modulator of vascular smooth muscle tension and shell gland motility during the egg-laying cycle. Endocrinology, 128, 1956-1958.
104. Tseng, L., Mazella, J. and Sun, B. (1986) Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486. Endocrinology, 118, 1312-1318.
105. Van Obberghen-Schilling, E.N., Roche, N.S., Flanders, K.C. et al. (1988) Transforming growth factor-β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem., 263, 7741-7746.
106. Vijayaraghavan, J., Scicli, A.G., Carretero, O.A. et al. (1990) The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem., 265, 14150-14155.
107. Wagner, O.F., Christ, G., Wojta, J. et al. (1992) Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem., 267, 16066-16068.
108. Wakefield, L., Kim, S.J., Glick, A. et al. (1990) Regulation of transforming growth factor-β subtypes by members of the steroid hormone superfamily. J. Cell Sci. Suppl., 13, 139-148.
109. Wewer, U.M., Faber, M., Liotta, L.A. and Albrechtsen, R. (1985) Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells. Lab. Invest., 53, 624-633.
110. Wiebke, J.L., Montrose-Rafizadeh, C., Zeitlin, P.L. and Guggino, W.B. (1992) Effect of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells. Biochim. Biophys. Acta, 1134, 105-111.
111. Wilbanks, G.A. and Streilein, J.W. (1992) Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol., 22, 1031-1036.
112. Xu, D., Emoto, N., Giaid, A. et al. (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell, 78, 473-485.
113. Yamamoto, M., Harm, S.C., Grasser, W.A. and Thiede, M.A. (1992) Parathyroid hormone-related protein in the rat urinary bladder: a. Proc. Natl. Acad. Sci. USA, 89, 5326-5330.
114. Yanagisawa, M. and Masaki, T. (1989) Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem. Pharmacol., 38, 1877-1883.